ESC 365 - Cardiovascular disease risk in people with diabetes in the era of universal diabetes screening

ESC Professional Premium Access

Cardiovascular disease risk in people with diabetes in the era of universal diabetes screening

Session: Obesity and diabetes: risk assessment and prognosis

Topic: Scores

Speaker: Miss J. Liang (Auckland, NZ)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Miss Jingyuan Liang

The University of Auckland, Auckland (New Zealand)

1 presentation

0 follower

4 more presentations in this session

Persistence and Adherence to GLP-1 RA treatment in Type 2 Diabetes Mellitus: a Nationwide registry study

Speaker: Doctor M. Lassen (Boston, US)

Prognostic outcomes of masld and obesity in acute myocardial infarction

Speaker: Doctor G. Kong (Singapore, SG)

Interleukin-6 and suPAR improves prediction of all-cause mortality in type 1 diabetes - the Thousand & 1 Study

Speaker: Doctor H. Bahrami (Herlev, DK)

Glucose lowering drugs with proven cardiovascular benefit following acute coronary syndrome in type 2 diabetes: treatment gaps and outcomes

Speaker: Doctor I. Naoum (Haifa, IL)

Access the full session

Obesity and diabetes: risk assessment and prognosis

Speakers: Miss J. Liang, Doctor M. Lassen, Doctor G. Kong, Doctor H. Bahrami, Doctor I. Naoum

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources